S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.05%) $0.791
USD/RUB
(0.86%) $85.73

के लिए वास्तविक समय के अद्यतन Fresenius SE & Co. KGaA [FSNUY]

एक्सचेंज: OTC क्षेत्र: Healthcare उद्योग: Medical Care Facilities
अंतिम अद्यतन29 Jun 2024 @ 00:43

0.00% $ 7.46

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 00:43):
Our systems believe the stock currently is undervalued by 0.81% compare to its pairs and should correct upwards.

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed...

Stats
आज की मात्रा 25 709
औसत मात्रा 64 070
बाजार मूल्य 16.81B
EPS $0.490 ( Q1 | 2024-03-31 )
अगली कमाई की तारीख ( $0 ) 2024-08-07
Last Dividend $0.247 ( 2023-05-18 )
Next Dividend $0 ( N/A )
P/E 37.30
(Sector) 0
(Industry) 0
ATR14 $0.0210 (0.28%)
ASSF 0.00%
BDULF 0.00%
EPWCF 0.00%
FSNUY 0.00%
GENN 0.00%
NMMCF 0.00%
PHCI 0.00%
RKAGY -7.07%
RMYHY 0.00%
RYHTY -0.79%
TPIA 0.00%
UHID -54.66%
सहसंबंध (AI algo v.1.1b): Undervalued: 0.81% $7.58 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.16 (neutral)
छोटा: 0.52 (weak)
Signal:(55.452) Neutral

Fresenius SE & Co. KGaA सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Fresenius SE & Co. KGaA सहसंबंध - मुद्रा/वस्त्र

The country flag -0.21
( neutral )
The country flag -0.19
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.32
( neutral )

Fresenius SE & Co. KGaA वित्तीय

Annual 2023
राजस्व: $22.30B
सकल लाभ: $5.06B (22.68 %)
EPS: $-1.050
FY 2023
राजस्व: $22.30B
सकल लाभ: $5.06B (22.68 %)
EPS: $-1.050
FY 2022
राजस्व: $40.84B
सकल लाभ: $10.73B (26.26 %)
EPS: $3.77
FY 2021
राजस्व: $37.52B
सकल लाभ: $10.31B (27.48 %)
EPS: $0.815

Financial Reports:

No articles found.

Fresenius SE & Co. KGaA Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.247
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Fresenius SE & Co. KGaA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.26 - average (75.56%) | Divividend Growth Potential Score: 1.036 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.119 2013-05-15
Last Dividend $0.247 2023-05-18
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 11 --
Total Paid Out $2.15 --
Avg. Dividend % Per Year 0.00% --
Score 1.7 --
Div. Sustainability Score 6.26
Div.Growth Potential Score 1.036
Div. Directional Score 3.65 --
Next Divdend (Est)
(2025-04-04)
$0.254 Estimate 3.11 %
Dividend Stability
0.25 Very Poor
Dividend Score
1.70
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
18 May 2023 $0.247 13 May 2023 19 May 2023 30 May 2023
16 May 2022 $0.242 30 Nov -0001 30 Nov -0001 21 Jun 2022
24 May 2021 $0.267 19 May 2021 25 May 2021 03 Jun 2021
31 Aug 2020 $0.238 10 Jul 2020 01 Sep 2020 10 Sep 2020
20 May 2019 $0.225 08 Apr 2019 21 May 2019 30 May 2019
21 May 2018 $0.230 30 Nov -0001 22 May 2018 01 Jun 2018
15 May 2017 $0.164 29 Jun 2017 17 May 2017 24 May 2017
11 May 2016 $0.155 30 Nov -0001 13 May 2016 23 May 2016
18 May 2015 $0.123 30 Nov -0001 20 May 2015 29 May 2015
14 May 2014 $0.143 30 Nov -0001 16 May 2014 27 May 2014
15 May 2013 $0.119 30 Nov -0001 17 May 2013 28 May 2013

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TTNDF Ex Dividend Knight 2023-08-29 Annually 0 0.00%
ENLAY Ex Dividend Knight 2023-07-24 Semi-Annually 0 0.00%
PNGAY Ex Dividend Knight 2023-09-08 Semi-Annually 0 0.00%
CHBH Ex Dividend Knight 2023-10-12 Quarterly 0 0.00%
LFGP Ex Dividend Junior 2023-08-17 Quarterly 0 0.00%
AGLXY Ex Dividend Junior 2023-08-23 Annually 0 0.00%
WYGPY Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
GTPS Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
SKLTY Ex Dividend Knight 2023-09-05 Annually 0 0.00%
COIHY Ex Dividend Knight 2023-08-31 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.02431.500-0.486-0.729[0 - 0.5]
returnOnAssetsTTM-0.01491.200-0.498-0.598[0 - 0.3]
returnOnEquityTTM-0.03371.500-1.486-2.23[0.1 - 1]
payoutRatioTTM-1.778-1.000-10.0010.00[0 - 1]
currentRatioTTM1.3540.8008.236.59[1 - 3]
quickRatioTTM0.6030.800-1.161-0.929[0.8 - 2.5]
cashRatioTTM0.1221.500-0.435-0.653[0.2 - 2]
debtRatioTTM0.287-1.5005.21-7.82[0 - 0.6]
interestCoverageTTM3.111.0009.969.96[3 - 30]
operatingCashFlowPerShareTTM7.602.007.4710.00[0 - 30]
freeCashFlowPerShareTTM5.582.007.2110.00[0 - 20]
debtEquityRatioTTM0.654-1.5007.38-10.00[0 - 2.5]
grossProfitMarginTTM0.2311.0009.489.48[0.2 - 0.8]
operatingProfitMarginTTM0.05991.000-0.803-0.803[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3371.0009.249.24[0.2 - 2]
assetTurnoverTTM0.6160.8009.237.38[0.5 - 2]
Total Score6.26

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-5.921.000-0.6990[1 - 100]
returnOnEquityTTM-0.03372.50-0.955-2.23[0.1 - 1.5]
freeCashFlowPerShareTTM5.582.008.1410.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM7.602.007.4710.00[0 - 30]
payoutRatioTTM-1.7781.500-10.0010.00[0 - 1]
pegRatioTTM-0.01281.500-3.420[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1571.0008.570[0.1 - 0.5]
Total Score1.036

Fresenius SE & Co. KGaA Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 1.9233901500702 seconds
Number of API calls: 3
Number of DB calls: 9